KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $159.6 million.

  • Neogenomics' Cash & Current Investments fell 5873.84% to $159.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $159.6 million, marking a year-over-year decrease of 5873.84%. This contributed to the annual value of $159.6 million for FY2025, which is 5873.84% down from last year.
  • As of Q4 2025, Neogenomics' Cash & Current Investments stood at $159.6 million, which was down 5873.84% from $164.1 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Cash & Current Investments peaked at $802.7 million during Q1 2021, and registered a low of $159.6 million during Q4 2025.
  • Moreover, its 5-year median value for Cash & Current Investments was $412.3 million (2023), whereas its average is $415.0 million.
  • Per our database at Business Quant, Neogenomics' Cash & Current Investments skyrocketed by 83060.03% in 2021 and then crashed by 5873.84% in 2025.
  • Quarter analysis of 5 years shows Neogenomics' Cash & Current Investments stood at $515.4 million in 2021, then dropped by 15.02% to $438.0 million in 2022, then dropped by 5.2% to $415.2 million in 2023, then dropped by 6.83% to $386.8 million in 2024, then crashed by 58.74% to $159.6 million in 2025.
  • Its last three reported values are $159.6 million in Q4 2025, $164.1 million for Q3 2025, and $163.7 million during Q2 2025.